Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1362-1372

  Deola, Sara ^a   Panelli, Monica C ^a   Maric, Dragan ^b   Selleri, Silvia ^a,d   Dmitrieva, Natalia I ^c   Voss, Ching Y ^a   Klein, Harvey ^a   Stroncek, David ^a   Wang, Ena ^a   Marincola, Francesco M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD70 ANTIGEN; CHEMOATTRACTANT; CYTOKINE; EPITOPE; 5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VIVO CULTURE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; CELL CULTURE; CHEMISTRY; CYTOTOXICITY; GENETICS; IMMUNOLOGY; METABOLISM;

ANTIGEN PRESENTATION; ANTIGENS, CD27; ANTIGENS, CD70; B-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FLUORESCEINS; FLUORESCENT DYES; HUMANS; LYMPHOCYTE ACTIVATION; SUCCINIMIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 40749131713     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1362     Document Type: Article

References (40)

1. + memory T cell subsets in response to Ag or homeostatic cytokines. Blood 101: 4260-4266.
2. Schultz, K. R., J. P. Klarnet, R. S. Gieni, K. T. HayGlass, and P. D. Greenberg. 1990. The role of B cells for in vivo T cell responses to a friend virus-induced leukemia. Science 249: 921-923.
3. Yang, X., and R. C. Brunham. 1998. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J. Immunol. 161: 1439-1446.
4. Sarwal, M., M. S. Chua, N. Kambham, S. C. Hsieh, T. Satterwhite, M. Masek, and O. Salvatierra, Jr. 2003. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349: 125-138.
5. Cross, A. H., J. L. Stark, J. Lauber, M. J. Ramsbottom, and J. A. Lyons. 2006. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 180: 63-70.
6. + T cells following immunization. Blood 104: 1970-1978.
7. Adams, S. D., K. C. Barracchini, D. Chen, F. Robbins, L. Wang, P. Larsen, R. Luhm, and D. F. Stroncek. 2004. Ambiguous allele combinations in HLA class I and class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification. J. Transl. Med. 2: 30.
8. Brinckerhoff, L. H., V. V. Kalashnikov, L. W. Thompson, G. V. Yamshchikov, R. A. Pierce, H. S. Galavotti, V. H. Engelhard, and C. L. Slingluff, Jr. 1999. Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1 (27-35) peptide: implications for peptide vaccines. Int. J. Cancer 83: 326-334.
9. Lee, K.-H., M. C. Panelli, C. J. Kim, A. Riker, M. Roden, P. A. Fetsch, A. Abati, M. P. Bettinotti, S. A. Rosenberg, and F. M. Marincola. 1998. Functional dissociation between local and systemic immune response following peptide vaccination. J. Immunol. 161: 4183-4194.
10. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral Ag controlled by a gene in the MHC. Nature 345: 449-452.
11. Wang, E., L. Miller, G. A. Ohnmacht, E. Liu, and F. M. Marincola. 2000. High fidelity mRNA amplification for gene profiling using cDNA microarrays. Nat. Biotechnol. 17: 457-459.
12. Wang, E. 2005. RNA amplification for successful gene profiling analysis. J. Transl. Med. 3: 28.
13. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
14. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
15. Liu, L., M. K. Callahan, D. Huang, and R. M. Ransohoff. 2005. Chemokine receptor CXCR3: an unexpected enigma. Curr. Top. Dev. Biol. 68: 149-181.
16. + central memory T cells. J. Exp. Med. 200: 725-735.
17. + T cells in the lungs of patients with HIV infection and T cell alveolitis. Am. J. Respir. Crit. Care Med. 162: 1466-1473.
18. Heller, E. A., E. Liu, A. M. Tager, Q. Yuan, A. Y. Lin, N. Ahluwalia, K. Jones, S. L. Koehn, V. M. Lok, E. Aikawa, et al. 2006. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113: 2301-2312.
19. Hendriks, J., L. A. Gravestein, K. Tesselaar, R. A. W. van Lier, M. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1: 433-440.
20. Hendriks, J., Y. Xiao, and J. Borst. 2003. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198: 1369-1380.
21. + T cells. Proc. Natl. Acad. Sci. USA 101: 15154-15159.
22. Campbell, D. J., C. H. Kim, and E. C. Butcher. 2003. Chemokines in the systemic organization of immunity. Immunol. Rev. 195: 58-71.
23. + T cells expressing CXCR3. J. Leukocyte Biol. 80: 320-329.
24. Sorensen, T. L. 2004. Targeting the chemokine receptor CXCR3 and its ligand CXCL10 in the CNS: potential therapy for inflammatory demyelinating disease? Curr. Neurovasc. Res. 1: 183-190.
25. Hancock, W. W., W. Gao, V. Csizmadia, K. L. Faia, N. Shemmeri, and A. D. Luster. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193: 975-980.
26. Zhang, Z., L. Kaptanoglu, Y. Tang, D. Ivancic, S. M. Rao, A. Luster, T. A. Barrett, and J. Fryer. 2004. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. Gastroenterology 126: 809-818.
27. Schaniel, C., E. Pardali, F. Sallusto, M. Speletas, C. Ruedl, T. Shimizu, T. Seidl, J. Andersson, F. Melchers, A. G. Rolink, and P. Sideras. 1998. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med. 188: 451-463.
28. Schaniel, C., F. Sallusto, C. Ruedl, P. Sideras, F. Melchers, and A. G. Rolink. 1999. Three chemokines with potential functions in T lymphocyte-independent and -dependent B lymphocyte stimulation. Eur. J. Immunol. 29: 2934-2947.
29. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
30. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475-482.
31. Ishida, T., T. Ishii, A. Inagaki, H. Yano, H. Komatsu, S. Iida, H. Inagaki, and R. Ueda. 2006. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res. 66: 5716-5722.
32. Bouneaud, C., Z. Garcia, P. Kourilsky, and C. Pannetier. 2005. Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo. J. Exp. Med. 201: 579-590.
33. Lanzavecchia, A. 1997. Understanding the mechanisms of sustained signaling and T cell activation. J. Exp. Med. 185: 1717-1719.
34. + T cells. J. Exp. Med. 199: 925-936.
35. + central and effector memory T cell subsets are largely distinct. Immunity 18: 193-204.
36. Langenkamp, A., G. Casorati, C. Garavaglia, P. Dellabona, A. Lanzavecchia, and F. Sallusto. 2002. T cell priming by dendritic cells: thresholds for proliferation, differentiation and death, and intraclonal functional diversification. Eur. J. Immunol. 32: 2046-2054.
37. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
38. Xiao, Y., J. Hendriks, P. Langerak, H. Jacobs, and J. Borst. 2004. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J. Immunol. 172: 7432-7441.
39. + T cell memory. Science 297: 2060-2063.
40. + T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus. J. Immunol. 157: 4079-4086.